real peptides FAQ

You're either a slow CYP1A2 metaboliser or you're taking melatonin too late in your sleep window. Slow metabolisers clear melatonin at half the rate of fast metabolisers, meaning circulating melatonin persists into morning hours and suppresses cortisol awakening response. The hormonal signal that transitions you from sleep to wakefulness. If grogginess is consistent, reduce your dose to 0.3mg and take it earlier (90–120 minutes before bed instead of 60). Alternatively, switch to immediate-release formulations only. Extended-release melatonin is a common culprit for next-day sedation because it delivers melatonin well past the point your body needs it.

Administer the missed dose as soon as you remember if fewer than 12 hours have passed, then resume the regular schedule the next day. If more than 12 hours have elapsed, skip the missed dose entirely and continue with the next scheduled administration. Do not double-dose to compensate. AOD-9604's mechanism relies on consistent receptor activation, not cumulative dosing. Missing occasional doses reduces overall research efficacy but doesn't require protocol adjustment.

Contact the supplier for a replacement if the vial spent more than 48 hours above 25°C. Peptide degradation at room temperature is a time-and-temperature function: short excursions (under 24 hours at 20–25°C) cause minimal loss, but extended exposure denatures the peptide's tertiary structure. You cannot determine degradation level visually. Lyophilized powder looks identical whether it's 98% pure or 60% degraded. Third-party suppliers worth using include temperature loggers in shipments or offer cold-chain guarantees. Real Peptides ships with insulated packaging and temperature monitoring to prevent this scenario entirely. If your supplier doesn't provide shipping documentation or refuses replacement after confirmed temperature exposure, that's a red flag about their quality controls across all products.

Administer the missed dose as soon as you remember if fewer than 48 hours have passed, then resume the regular schedule. TB-4 tissue concentrations drop below the actin-binding threshold within 24–30 hours, so a 2-day gap during loading doesn't completely reset progress but does create a temporary reduction in repair signalling. If more than 48 hours have passed, skip the missed dose and continue with the next scheduled administration. Doubling up doses doesn't compensate for the missed tissue exposure window and increases the risk of injection site reactions.

You've mistimed the dose relative to your circadian readiness for sleep. Melatonin isn't a sedative. It's a phase-advance signal that requires 30–90 minutes to align receptor activity with your intended sleep window. If you take it at 11 p.m. and expect to fall asleep by 11:15 p.m., your MT1 receptors haven't had time to suppress SCN firing rate, and your circadian system hasn't shifted into sleep-permissive mode. Move your dose earlier. 60–90 minutes before lights-out. And eliminate light exposure in that window to allow the signal to take hold.

Current research supports daily Adamax use for up to 24 weeks without tolerance development or serious adverse effects, based on Russian clinical data. Monitor thyroid function (TSH, free T3/T4) every 12 weeks if using 10mg daily, as chronic melanocortin receptor activation can theoretically suppress TSH secretion in susceptible individuals, though this is rare at cognitive-enhancement doses. Cycling off Adamax one week every 12–16 weeks may preserve receptor sensitivity.

Do not purchase from that supplier. Refusal to provide independent lab verification. Or offering only in-house testing results. Is the clearest red flag for unverified or counterfeit peptides. Legitimate research-grade suppliers use accredited third-party labs (e.g., Janoshik Analytical, ChemTox) to verify every batch because in-house testing lacks the transparency and accountability that external validation provides. A supplier unwilling to share third-party COA data either has not tested the peptide, has tested it and the results failed quality benchmarks, or is reselling unverified product from another source. In every case, the risk of receiving counterfeit or contaminated peptides is unacceptably high.

Check your baseline methyl donor status and cofactor intake. If homocysteine is elevated or you're not supplementing folate and B6, LIPO-C is correcting a deficiency rather than providing surplus methyl donors for performance. Add 400–800 mcg methylfolate and 25–50mg pyridoxine daily, then reassess after two weeks. The energy effect becomes noticeable once methylation pathways shift from repair mode to surplus mode.

Doses above 2mg per injection are uncommon in published LL-37 immune research but not unheard of in antimicrobial efficacy models. Reconstitute at higher concentration (e.g., 5mg peptide in 2mL water for 2.5mg/mL) rather than injecting larger volumes. Subcutaneous injection volumes above 1.5mL per site cause tissue distension and inconsistent absorption. If your protocol requires 3mg per dose, split it into two 1.5mg injections at separate sites rather than one 3mg bolus.

Reduce your dose by 25–50% and verify you're using bacteriostatic saline for reconstitution. Nasal irritation typically indicates either preservative contamination or administration technique error. You should tilt your head slightly forward during administration to prevent solution from dripping into the throat. If irritation persists at reduced dose, switch to subcutaneous administration at 60% of your intranasal dose to bypass nasal mucosa while maintaining therapeutic effect.

Request a Certificate of Analysis (CoA) from the supplier. Reputable peptide manufacturers provide this document for every lot, listing exact purity determined by HPLC. If unavailable, assume 95% purity as a conservative default and note this assumption in protocol documentation. Using stated mass without purity correction systematically overdoses by 5% if actual purity is 95%, which may be acceptable for preliminary screening but fails Good Laboratory Practice standards for publication-grade research. Real Peptides provides full CoA documentation with exact purity values for every batch, eliminating this guesswork.

Resume the protocol immediately without attempting to double-dose. Applying 4mg in a single day does not compensate for missed exposure and increases the risk of localised irritation. The follicle response to copper peptides is cumulative over weeks, not days, so short lapses (48–72 hours) have minimal impact on final outcomes as long as the protocol continues for the full 12 weeks. If you miss more than one week of application, consider restarting the 12-week timeline from the beginning to ensure adequate anagen-phase coverage.

Administer the protocol as planned. Delayed initiation still provides benefit, but the magnitude decreases as fibrotic remodeling progresses. The peak angiogenic window is 0–7 days post-injury; starting at day 10–14 shifts the primary benefit from cardiomyocyte salvage to scar border stabilisation. Animal models show 25–30% infarct size reduction when TB-4 is started at day 7, compared to 45–50% when started at day 1. Late administration (beyond 30 days) targets chronic remodeling rather than acute repair. Evidence for efficacy in this context is limited to small veterinary case series.

Yes, but you must add methylated B-vitamin cofactors to prevent homocysteine accumulation. MTHFR C677T and A1298C polymorphisms reduce the enzyme activity required to convert dietary folate into methylfolate, the active form needed for methionine metabolism. Without adequate methylfolate and methylcobalamin (active B12), methionine from LIPO-C cannot efficiently convert to SAMe. Instead it accumulates as homocysteine, an inflammatory metabolite linked to cardiovascular risk. Supplement with 400–800mcg methylfolate and 1000mcg methylcobalamin daily alongside your LIPO-C protocol. If you experience fatigue, brain fog, or elevated homocysteine on lab work (>10 µmol/L), reduce LIPO-C frequency to once weekly until cofactor support normalizes methylation markers.

Cloudiness indicates one of three failures: impure amino acid precursors containing protein aggregates, incorrect molar ratios producing insoluble complexes, or microbial contamination from non-sterile compounding. Do not inject cloudy peptide solutions under any circumstance. Particulate matter can cause injection site reactions, embolism, or systemic inflammatory response. Filter the solution through a 0.22-micron sterile syringe filter as a diagnostic test: if cloudiness persists post-filtration, the formulation itself is compromised and should be discarded. Authentic LIPO-C from cGMP facilities produces optically clear solution 100% of the time when reconstituted correctly.

Discard it immediately. Cloudiness indicates either bacterial contamination or peptide aggregation, both of which render the solution unusable. AOD-9604 should remain clear to slightly opalescent throughout the 28-day use window. Cloudiness that appears after refrigeration suggests the vial was exposed to temperature fluctuations or the bacteriostatic water was contaminated. Never attempt to filter or clarify cloudy peptide solutions. The structural damage is already done.

The GH pulse will be blunted by 60–80%, but the dose isn't wasted. Some growth hormone will still be released. Do not re-inject to 'make up' for the reduced pulse; doubling up on doses increases the risk of insulin resistance without improving joint repair signaling. Resume your normal schedule at the next fasted administration window. One mistimed injection out of 14 weekly doses has minimal impact on cumulative IGF-1 synthesis.

VIP stimulates intestinal smooth muscle relaxation and increases intestinal secretion through VPAC receptor activation in the gut. Mild cramping or loose stools in the 2–4 hours post-injection occurs in 4–7% of users and correlates with doses above 20 mcg. This is mechanism-driven, not pathological. If cramping is severe or persists beyond 6 hours, contamination (bacterial endotoxins in the reconstituted solution) is more likely than VIP action. Discard the vial and source fresh peptide.

Walk away. The only reason to withhold lab contact details is that the COA is fabricated or the lab doesn't want to be associated with verification calls. Authentic third-party testing labs expect verification inquiries. They provide contact information specifically so researchers can confirm the document's legitimacy. We've seen counterfeit COAs with invented lab names, real lab names with forged signatures, and real COAs from legitimate labs applied to different products entirely. If the supplier resists giving you the lab's phone number or email, they're hiding something.

Acidic pH below 5.0 indicates either degradation byproducts from improper storage or the use of non-pharmaceutical-grade amino acids containing acidic impurities. Do not use solutions with pH <5.0 or >7.0. Extreme pH causes tissue damage at injection sites and alters the ionisation state of active compounds, reducing bioavailability. Authentic LIPO-C formulations include buffering agents (typically sodium phosphate or citrate buffer) that maintain physiological pH range regardless of minor environmental variations. Persistent low pH across multiple vials from the same supplier confirms systematic formulation failure.